|
Jul 28
|
Healthcare Earnings Are Coming. 4 Big Questions for CVS, Humana, Merck, UnitedHealth, and More.
|
|
Jul 28
|
Will These 5 Pharma/Biotech Bigwigs Surpass Q2 Earnings Forecasts?
|
|
Jul 28
|
How To Earn $500 A Month From Merck Stock Ahead Of Q2 Earnings
|
|
Jul 28
|
Trade Outlook Lifts Wall Street Pre-Bell; Asia Choppy, Europe Up
|
|
Jul 28
|
Moderna Announces Data to be Presented at ESMO Congress 2025
|
|
Jul 28
|
3 Surprisingly Underrated Stocks to Buy Right Now
|
|
Jul 28
|
Blockbuster Drugs on Patent Cliffs Research Report 2025 | 2030 Patent Cliff to Be Largest Since 2010, Hitting Blockbusters Like Keytruda, Eliquis, and Darzalex
|
|
Jul 28
|
Leerink Partners Slashes PT on Merck & Co. (MRK) to $92 From $115
|
|
Jul 28
|
What To Expect From Merck’s (MRK) Q2 Earnings
|
|
Jul 27
|
Merck (MRK) as a Reliable Dividend Player in the Dogs of the Dow Lineup
|
|
Jul 27
|
Federal Reserve meeting, July jobs report, and Big Tech earnings: What to watch this week
|
|
Jul 25
|
Metastatic Hormone Refractory Prostate Cancer Pipeline Market Research Report 2025 | In-depth Analysis of 180+ Companies and Over 200 Drugs in Development
|
|
Jul 25
|
Apple, Amazon, Meta Highlight Earnings Calendar; S&P 500 Titan Sets Up Ahead Of Results
|
|
Jul 25
|
Saudi Arabia IVF Market Outlook Report 2025-2033 | Rising Infertility, Medical Advances, Government Supports and Societal Shifts Driving Growth
|
|
Jul 25
|
Merck Q2 Earnings in the Cards: Buy, Sell or Hold Ahead of Results?
|
|
Jul 25
|
U.S. Keytruda Market Research Report 2025 | Merck's Keytruda Faces Challenges as Patent Expiry Approaches in 2028 - Forecast to 2033
|
|
Jul 25
|
Post-Operative Nausea and Vomiting Market Report 2025: Surge in Surgical Procedures Fuels $2.97 Billion Growth in PONV Market by 2029
|
|
Jul 25
|
UBS Bullish on Merck (MRK) Following Verona Pharma Purchase
|
|
Jul 24
|
Dr. Reddy's Q1 Earnings Beat Estimates, Generics Sales Boost Revenues
|
|
Jul 24
|
Bristol Myers Gains 6.3% in a Month: Buy, Sell or Hold the Stock?
|